We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AACG
13176
ATA Creativity
AACG
$41.5M
$52K ﹤0.01%
+16,919
New +$52.9K
ADIL
13177
Adial Pharmaceuticals
ADIL
$8.71M
$52K ﹤0.01%
32
-87
-73% -$132K
CELG.RT
13178
Bristol-Myers Squibb Rights
CELG.RT
$224M
$52K ﹤0.01%
+215,051
New +$48K
CIG.C icon
13179
CEMIG Ordinary Shares
CIG.C
$8.12B
$52K ﹤0.01%
28,086
-93,859
-77% -$168K
DSWL icon
13180
Deswell Industries
DSWL
$49.9M
$52K ﹤0.01%
+10,955
New +$45K
NTWK icon
13181
NetSol Technologies
NTWK
$48.3M
$52K ﹤0.01%
+11,120
New +$50.5K
YHGJ icon
13182
Yunhong Green CTI Ltd
YHGJ
$8.82M
$52K ﹤0.01%
2,647
+1,645
+164% +$31.1K
ACOR
13183
CALL
DELISTED
Acorda Therapeutics
ACOR
$52K ﹤0.01%
545
-1,096
-67% -$95.9K
CHMA
13184
DELISTED
Chiasma, Inc. Common Stock
CHMA
$52K ﹤0.01%
10,890
-10,987
-50% -$41.4K
EZRA
13185
Reliance Global Group
EZRA
$2.02M
$51K ﹤0.01%
1
BNKK
13186
Bonk Inc
BNKK
$8.64M
$51K ﹤0.01%
+323
New +$50.5K
TLPH icon
13187
Talphera
TLPH
$63.8M
$51K ﹤0.01%
1,859
-1,447
-44% -$38.8K
SWBK.WS
13188
DELISTED
Switchback II Corporation Warrants, exercisable for one share of Class A Ordinary Share
SWBK.WS
$51K ﹤0.01%
37,785
+16,872
+81% +$25.1K
FSI icon
13189
Flexible Solutions
FSI
$64.2M
$50K ﹤0.01%
+12,734
New +$43.5K
NINE
13190
PUT
DELISTED
Nine Energy Service
NINE
$50K ﹤0.01%
16,900
-2,700
-14% -$6.13K
PZG icon
13191
Paramount Gold Nevada
PZG
$132M
$50K ﹤0.01%
51,306
-13,625
-21% -$14.1K
AIXC
13192
CALL
AIxCrypto Holdings Inc
AIXC
$13.7M
$50K ﹤0.01%
50
+13
+35% +$13.2K
SEEL
13193
CALL
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$50K ﹤0.01%
5
-7
-58% -$115K
CYTO
13194
PUT
DELISTED
Altamira Therapeutics Ltd
CYTO
$50K ﹤0.01%
35
-40
-53% -$54.9K
HIL
13195
CALL
DELISTED
Hill International, Inc. Common Stock
HIL
$50K ﹤0.01%
20,200
-39,500
-66% -$105K
EUSGW
13196
DELISTED
European Sustainable Growth Acquisition Corp. Warrant
EUSGW
$50K ﹤0.01%
50,000
-100
-0.2% -$76
ARAY icon
13197
PUT
Accuray
ARAY
$33.2M
$49K ﹤0.01%
10,800
-11,600
-52% -$54.3K
ATHE
13198
Alterity Therapeutics
ATHE
$86.8M
$49K ﹤0.01%
3,798
-2,703
-42% -$36.6K
BCDA icon
13199
CALL
BioCardia
BCDA
$14.5M
$49K ﹤0.01%
+820
New +$49.8K
DTSS icon
13200
Datasea Intelligent Technology Ltd
DTSS
$7.98M
$49K ﹤0.01%
1,311
-1,260
-49% -$52.8K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.